drugset
drugset / Trial / NCT07012746

A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss

NCT07012746 ↗

Not yet recruiting 60 enrolled Yilai Shu Hangzhou PhecdaMed Co., Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to explore the safety and efficacy of TJ0113 capsules in patients with age-related hearing loss.

Timeline

Start
2025-06-07
Primary completion
2026-12
Completion
2027-04

Drugs

EvaluationDrugModalityDoseRoute
Subject TJ0113 Unknown 200 mg Oral

Indications

presbycusis